First FDA Approved Potassium Phosphates Injection from CMP Pharma is Now Available
Farmville, NC—Specialty pharmaceutical company CMP Pharma, Inc. announced today that its Potassium Phosphates Injection, the first FDA Approved Potassium Phosphates Injection, is NOW Available. Health Care Providers have available for the first time an FDA approved potassium phosphates injection. The availability of this product will help alleviate supply concerns from previous market shortages of this critical phosphate repletion treatment. CMP Pharma’s Potassium Phosphates Injection is now available from National and Regional wholesalers.
Potassium Phosphates Injection is indicated as a source of phosphorus in intravenous fluids to correct hypophosphatemia in adults and pediatric patients 12 years of age and older when oral or enteral replacement is not possible, insufficient or contraindicated. Additionally, it is indicated as an additive for preparing specific parenteral fluid formulas when the needs of the patient cannot be met by standard electrolyte or nutrient solutions.